Lefebvre P - Search Results

1

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.

Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Lefebvre P, et al. Curr Med Res Opin. 2006 Sep;22(9):1623-31. doi: 10.1185/030079906X120968. Curr Med Res Opin. 2006. PMID: 16968565

2

Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.

Duh MS, Lefebvre P, Fastenau J, Piech CT, Waltzman RJ. Duh MS, et al. Among authors: lefebvre p. Oncologist. 2005 Jun-Jul;10(6):438-48. doi: 10.1634/theoncologist.10-6-438. Oncologist. 2005. PMID: 15967837 Free article.

3

Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.

Campos SM, Duh MS, Lefebvre P, Rosberg J. Campos SM, et al. Among authors: lefebvre p. J Natl Compr Canc Netw. 2005 Nov;3(6):807-16. doi: 10.6004/jnccn.2005.0049. J Natl Compr Canc Netw. 2005. PMID: 16316616

4

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.

Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Lefebvre P, et al. Curr Med Res Opin. 2006 Oct;22(10):1929-37. doi: 10.1185/030079906X132541. Curr Med Res Opin. 2006. PMID: 17022852

5

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations.

Duh MS, Mody SH, Scott McKenzie R, Lefebvre P, Gosselin A, Tak Piech C. Duh MS, et al. Among authors: lefebvre p. Clin Ther. 2006 Sep;28(9):1443-50. doi: 10.1016/j.clinthera.2006.09.020. Clin Ther. 2006. PMID: 17062316

6

Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.

Lefebvre P, Duh MS, Buteau S, Bookhart B, Mody SH. Lefebvre P, et al. J Am Soc Nephrol. 2006 Dec;17(12):3497-502. doi: 10.1681/ASN.2006030289. Epub 2006 Nov 2. J Am Soc Nephrol. 2006. PMID: 17082245

7

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.

Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Duh MS, et al. Among authors: lefebvre p. Drugs Aging. 2006;23(12):969-76. doi: 10.2165/00002512-200623120-00004. Drugs Aging. 2006. PMID: 17154661

8

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease.

Cremieux PY, Van Audenrode M, Lefebvre P. Cremieux PY, et al. Among authors: lefebvre p. Curr Med Res Opin. 2006 Dec;22(12):2329-36. doi: 10.1185/030079906X154024. Curr Med Res Opin. 2006. PMID: 17257447 Review.

9

The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.

Lefebvre P, Duh MS, Mody SH, Bookhart B, Piech CT. Lefebvre P, et al. Dis Manag. 2007 Feb;10(1):37-45. doi: 10.1089/dis.2006.626. Dis Manag. 2007. PMID: 17309363

10

Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.

Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Zilberberg MD, et al. Among authors: lefebvre p. Crit Care. 2007;11(3):R63. doi: 10.1186/cc5934. Crit Care. 2007. PMID: 17553147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,582 results

Search Page

Filters